Back to search
FDAFDA · Food and drugs·Recall number D-0533-2023

Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-474-60.

Published April 5, 2023 · Recall initiated: March 14, 2023

Summary

FDA records drug Class II recall D-0533-2023, published April 5, 2023 and initiated March 14, 2023. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 13,560 bottles; Lot: Lot #s: 22142462, 22142463, 22142464, Exp 5/2024; 22143000, 22143001, 22143002, Exp 6/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.

What to do

Voluntary: Firm initiated · Letter

Get an email if DABIGATRAN ETEXILATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DABIGATRAN ETEXILATE
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide in the USA.
UPC
0367877624600
Lot
Lot #s: 22142462, 22142463, 22142464, Exp 5/2024; 22143000, 22143001, 22143002, Exp 6/2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-474-60. recalled?

Yes. FDA published recall D-0533-2023 on April 5, 2023. Reported hazard: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DABIGATRAN ETEXILATE. UPC: 0367877624600.